相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Selective Targeting of Cancer Cells by Copper Ionophores: An Overview
Valentina Oliveri
FRONTIERS IN MOLECULAR BIOSCIENCES (2022)
Mir-488 alleviates chemoresistance and glycolysis of colorectal cancer by targeting PFKFB3
Xiaojing Deng et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2021)
Disulfiram and metformin combination anticancer effect reversible partly by antioxidant nitroglycerin and completely by NF-κB activator mebendazole in hamster fibrosarcoma
Kosta J. Popovic et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Diethyldithiocarbamate-copper complex (CuET) inhibits colorectal cancer progression via miR-16-5p and 15b-5p/ALDH1A3/PKM2 axis-mediated aerobic glycolysis pathway
Xin Huang et al.
ONCOGENESIS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibition
Chinmayee Sethy et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
The Role of Tumor-Stroma Interactions in Drug Resistance Within Tumor Microenvironment
Yanghong Ni et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Anti-Cancer Effects of Zotarolimus Combined with 5-Fluorouracil Treatment in HCT-116 Colorectal Cancer-Bearing BALB/c Nude Mice
Geng-Ruei Chang et al.
MOLECULES (2021)
Recent Advances in Repurposing Disulfiram and Disulfiram Derivatives as Copper-Dependent Anticancer Agents
Vinodh Kannappan et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
Could 3D models of cancer enhance drug screening?
Virginia Brancato et al.
BIOMATERIALS (2020)
Coencapsulation of disulfiram and doxorubicin in liposomes strongly reverses multidrug resistance in breast cancer cells
Francesca Rolle et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Targeting the NPL4 Adaptor of p97/VCP Segregase by Disulfiram as an Emerging Cancer Vulnerability Evokes Replication Stress and DNA Damage while Silencing the ATR Pathway
Dusana Majera et al.
CELLS (2020)
5-Fluorouracil resistance mechanisms in colorectal cancer: From classical pathways to promising processes
Sabrina Blondy et al.
CANCER SCIENCE (2020)
5-FU promotes stemness of colorectal cancer via p53-mediated WNT/β-catenin pathway activation
Yong-Hee Cho et al.
NATURE COMMUNICATIONS (2020)
Disulfiram as a Therapeutic Agent for Metastatic Malignant Melanoma-Old Myth or New Logos?
Francisco Meraz-Torres et al.
CANCERS (2020)
Lactic Acidosis Interferes With Toxicity of Perifosine to Colorectal Cancer Spheroids: Multimodal Imaging Analysis
Barbora Pavlatovska et al.
FRONTIERS IN ONCOLOGY (2020)
Disulfiram Chelated With Copper Inhibits the Growth of Gastric Cancer Cells by Modulating Stress Response and Wnt/β-catenin Signaling
Ling Wang et al.
FRONTIERS IN ONCOLOGY (2020)
Population Pharmacokinetics and Pharmacodynamics of Disulfiram on Inducing Latent HIV-1 Transcription in a Phase IIb Trial
Sulggi A. Lee et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Disulfiram modulates ROS accumulation and overcomes synergistically cisplatin resistance in breast cancer cell lines
Zhi Yang et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Repurposing Disulfiram as An Anti-Cancer Agent: Updated Review on Literature and Patents
Elmira Ekinci et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2019)
Disulfiram Overcomes Cisplatin Resistance in Human Embryonal Carcinoma Cells
Silvia Schmidtova et al.
CANCERS (2019)
Drug Penetration Analysis in 3D Cell Cultures Using Fiducial-Based Semiautomatic Coregistration of MALDI MSI and Immunofluorescence Images
Marketa Machalkova et al.
ANALYTICAL CHEMISTRY (2019)
Ex vivo tissue slice culture system to measure drug-response rates of hepatic metastatic colorectal cancer
Steve Z. Martin et al.
BMC CANCER (2019)
CD44/CD133-Positive Colorectal Cancer Stem Cells are Sensitive to Trifluridine Exposure
Kenta Tsunekuni et al.
SCIENTIFIC REPORTS (2019)
Organotypic tumor slice cultures provide a versatile platform for immuno-oncology and drug discovery
Ramya Sivakumar et al.
ONCOIMMUNOLOGY (2019)
ALDH1A inhibition sensitizes colon cancer cells to chemotherapy
Z. Kozovska et al.
BMC CANCER (2018)
Regulation of Tumor Progression by Programmed Necrosis
Su Yeon Lee et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
ATM Is Required for the Repair of Oxaliplatin-Induced DNA Damage in Colorectal Cancer
Christopher J. Bakkenist et al.
CLINICAL COLORECTAL CANCER (2018)
Wnt pathway is involved in 5-FU drug resistance of colorectal cancer cells
Lingfeng He et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
Selective elimination of neuroblastoma cells by synergistic effect of Akt kinase inhibitor and tetrathiomolybdate
Jarmila Navratilova et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2017)
Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4
Zdenek Skrott et al.
NATURE (2017)
In Vitro Collapsing Colon Cancer Cells by Selectivity of Disulfiram-Loaded Charge Switchable Nanoparticles Against Cancer Stem Cells
Marwa M. Abu-Serie et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2017)
Disulfiram/copper selectively eradicates AML leukemia stem cells in vitro and in vivo by simultaneous induction of ROS-JNK and inhibition of NF-kB and Nrf2
Bing Xu et al.
CELL DEATH & DISEASE (2017)
QuPath: Open source software for digital pathology image analysis
Peter Bankhead et al.
SCIENTIFIC REPORTS (2017)
Ex vivo tumor culture systems for functional drug testing and therapy response prediction
Titia G. Meijer et al.
FUTURE SCIENCE OA (2017)
Disulfiram suppresses cancer stem-like properties and STAT3 signaling in triple-negative breast cancer cells
Yoon-Jae Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Role of CD44high/CD133high HCT-116 cells in the tumorigenesis of colon cancer
Jin-Yong Zhou et al.
ONCOTARGET (2016)
CD133+CD24lo defines a 5-Fluorouracil-resistant colon cancer stem cell-like phenotype
Amy V. Paschall et al.
ONCOTARGET (2016)
The biology and function of fibroblasts in cancer
Raghu Kalluri
NATURE REVIEWS CANCER (2016)
Thymidylate synthase expression in circulating tumor cells: A new tool to predict 5-fluorouracil resistance in metastatic colorectal cancer patients
Emne Ali Abdallah et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
5-Fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits
Corti Denise et al.
ONCOTARGET (2015)
High-Throughput Chemical Screens Identify Disulfiram as an Inhibitor of Human Glioblastoma Stem Cells
Parvinder Hothi et al.
Oncotarget (2015)
Inhibitory effect of Disulfiram/copper complex on non-small cell lung cancer cells
Lincan Duan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Three-dimensional models of cancer for pharmacology and cancer cell biology: Capturing tumor complexity in vitro/ex vivo
John A. Hickman et al.
BIOTECHNOLOGY JOURNAL (2014)
Synergistic Enhancement of Cancer Therapy Using a Combination of Ceramide and Docetaxel
Li-Xia Feng et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Multiplexed immunohistochemistry, imaging, and quantitation: A review, with an assessment of Tyramide signal amplification, multispectral imaging and multiplex analysis
Edward C. Stack et al.
METHODS (2014)
Evaluation of Cancer Stem Cell Markers CD133, CD44, CD24: Association with AKT Isoforms and Radiation Resistance in Colon Cancer Cells
Sara Haggblad Sahlberg et al.
PLOS ONE (2014)
CD44 Expressed on Cancer-Associated Fibroblasts Is a Functional Molecule Supporting the Stemness and Drug Resistance of Malignant Cancer Cells in the Tumor Microenvironment
Yumi Kinugasa et al.
STEM CELLS (2014)
Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years
Mariusz Panczyk
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer
Chunxia Wang et al.
ONCOLOGY REPORTS (2012)
Aldehyde Dehydrogenase Inhibitors: a Comprehensive Review of the Pharmacology, Mechanism of Action, Substrate Specificity, and Clinical Application
Vindhya Koppaka et al.
PHARMACOLOGICAL REVIEWS (2012)
Disulfiram modulated ROS-MAPK and NFκB pathways and targeted breast cancer cells with cancer stem cell-like properties
N. C. Yip et al.
BRITISH JOURNAL OF CANCER (2011)
Disulfiram/copper complex inhibiting NFκB activity and potentiating cytotoxic effect of gemcitabine on colon and breast cancer cell lines
Xiaoxia Guo et al.
CANCER LETTERS (2010)
Preclinical model of organotypic culture for pharmacodynamic profiling of human tumors
Valentina Vaira et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis
O. Fluge et al.
BRITISH JOURNAL OF CANCER (2009)
Elimination of Colon Cancer Stem-Like Cells by the Combination of Curcumin and FOLFOX
Yingjie Yu et al.
TRANSLATIONAL ONCOLOGY (2009)
CD44 is of Functional Importance for Colorectal Cancer Stem Cells
Lei Du et al.
CLINICAL CANCER RESEARCH (2008)
Pharmacokinetic and demographic markers of 5-fluorouracil toxicity in 181 patients on adjuvant therapy for colorectal cancer
M. Gusella et al.
ANNALS OF ONCOLOGY (2006)
The molecular basis of the action of disulfiram as a modulator of the multidrug resistance-linked ATP binding cassette transporters MDR1 (ABCB1) and MRP1 (ABCC1)
ZE Sauna et al.
MOLECULAR PHARMACOLOGY (2004)
Disulfiram-mediated inhibition of NF-κB activity enhances cytotoxicity of 5-fluorouracil in human colorectal cancer cell lines
WG Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Mitochondrial injury by disulfiram: two different mechanisms of the mitochondrial permeability transition
MY Balakirev et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2001)
分享论文
